You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

Finerenone for treating chronic kidney disease in type 2 diabetes

  • Technology appraisal guidance
  • Reference number: TA877
  • Published:  23 March 2023
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Final draft guidance
  2. Draft guidance
  3. Invitation to participate
  4. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

History

A list of downloadable documents created during development.

Final draft guidance

  • Final draft guidance

  • Final appraisal document (PDF 340 KB)

    Published:
    21 February 2023
  • Committee papers (PDF 2.23 MB)

    Published:
    21 February 2023
  • Public committee slides (PowerPoint 1.81 MB)

    Published:
    21 February 2023

Draft guidance

  • Draft guidance

  • Appraisal consultation document (PDF version) (PDF 343 KB)

    Published:
    17 May 2022
  • Committee papers (PDF 4.61 MB)

    Published:
    17 May 2022
  • Appraisal consultation document (online commenting)

  • Public committee slides (PDF 1.54 MB)

    Published:
    17 May 2022

Invitation to participate

  • Final scope (PDF 173 KB)

    Published:
    28 June 2021
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 413 KB)

    Published:
    28 June 2021
  • Final stakeholder list (PDF 158 KB)

    Published:
    28 June 2021
  • Equality impact assessment (Scoping) (PDF 126 KB)

    Published:
    29 June 2021

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Draft scope post referral (PDF 180 KB)

    Published:
    03 March 2021
  • Draft matrix post referral (PDF 158 KB)

    Published:
    03 March 2021
Back to top